USP48 Inhibition as a Potential Therapeutic Target for Patients with T-acute Lymphoblastic Leukemia

Authors

Matthew T. Ye, The University of Texas MD Anderson Cancer CenterFollow
Yaling Yang, The University of Texas MD Anderson Cancer Center
Xianbao Huang, The University of Texas MD Anderson Cancer Center
Hua He, The University of Texas MD Anderson Cancer Center
M James You, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

T-ALL, Deubiquitinating enzymes, USP48, BRAT1

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

High School Summer Program

Recommended Citation

Ye, Matthew T.; Yang, Yaling; Huang, Xianbao; He, Hua; and You, M James, "USP48 Inhibition as a Potential Therapeutic Target for Patients with T-acute Lymphoblastic Leukemia" (2021). Summer Experience 2021. 117.
https://openworks.mdanderson.org/sumexp21/117